Multiple sclerosis : oral versus parenteral treatment
| dc.contributor.advisor | Pórszász, Róbert | |
| dc.contributor.advisordept | Debreceni Egyetem::Általános Orvostudományi Kar::Farmakológiai és Farmakoterápiai Intézet | hu_HU |
| dc.contributor.author | Zohoor, Asiri | |
| dc.contributor.department | DE--Általános Orvostudományi Kar | hu_HU |
| dc.contributor.opponent | Drimba, László | |
| dc.contributor.opponent | Szentmiklósi, József András | |
| dc.contributor.opponentdept | Kenézy Kórház Aneszteziológiai és Intenziv Therápiás Osztály | hu_HU |
| dc.contributor.opponentdept | Debreceni Egyetem::Általános Orvostudományi Kar::Farmakológiai és Farmakoterápiai Intézet | hu_HU |
| dc.date.accessioned | 2015-11-19T13:17:47Z | |
| dc.date.available | 2015-11-19T13:17:47Z | |
| dc.date.created | 2015-06-12 | |
| dc.description.abstract | This thesis was prepared following deepening interest in the existing therapies options available for MS, a disease which presently has no cure. I wrote this thesis introducing and pointing out the global burden of MS, its prevalence, morbidity and mortality. I compared parenteral and oral drug treatment of MS itemizing the benefits and untoward effects of either one, the Efficiency,Cost and the new developments in the management and hopes for the future of MS were also discussed. | hu_HU |
| dc.description.course | általános orvos | hu_HU |
| dc.description.courselang | angol | hu_HU |
| dc.description.degree | egységes, osztatlan | hu_HU |
| dc.format.extent | 35 | hu_HU |
| dc.identifier.uri | http://hdl.handle.net/2437/218611 | |
| dc.language.iso | en | hu_HU |
| dc.subject | multiple sclerosis | hu_HU |
| dc.subject.dspace | DEENK Témalista::Orvostudomány | hu_HU |
| dc.title | Multiple sclerosis : oral versus parenteral treatment | hu_HU |